Effect of growth hormone and 17β-oestradiol treatment on metabolism and body composition in girls with Turner syndrome

Clinical Endocrinology

Volumn 62, Issue 5, 2005, Pages 616-622

  Gravholt, Claus Højbjerg ^a   Hjerrild, Britta Eilersen ^a   Naeraa, Rune Weis ^a,b   Engbaek, Frode ^a   Mosekilde, Leif ^a   Christiansen, Jens Sandahl ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b Randers Centralsygehus   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTROGEN; GLUCOSE; GROWTH FACTOR; HUMAN GROWTH HORMONE; INSULIN; PLACEBO;

ADOLESCENT; ADULT; ARTICLE; BODY COMPOSITION; BONE MINERAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOUBLE BLIND PROCEDURE; FEMALE; GLUCONEOGENESIS; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; LEAN BODY WEIGHT; LIPOLYSIS; METABOLISM; ORAL GLUCOSE TOLERANCE TEST; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TURNER SYNDROME;

ADOLESCENT; BLOOD GLUCOSE; BODY COMPOSITION; BONE DENSITY; CASE-CONTROL STUDIES; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ESTRADIOL; FEMALE; GLUCAGON; GLUCOSE TOLERANCE TEST; GROWTH HORMONE; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; LIPIDS; TURNER SYNDROME;

EID: 18444397176     PISSN: 03000664     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2005.02270.x     Document Type: Article

References (32)

1. Rosenfeld, R.G., Attie, K.M., Frane, J., Brasel, J.A., Burstein, S., Cara, J.F., Chernausek, S., Gotlin, R.W., Kuntze, J., Lippe, B.M., Mahoney, C.P., Moore, W.V., Saenger, P. & Johanson, A.J. (1998) Growth hormone therapy of Turner's syndrome: beneficial effect on adult height. Journal of Pediatrics, 132, 319-324.
2. Sas, T.C., Muinck Keizer-Schrama, S.M., Stijnen, T., Jansen, M., Otten, B.J., Hoorweg-Nijman, J.J., Vulsma, T., Massa, G.G., Rouwe, C.W., Reeser, H.M., Gerver, W.J., Gosen, J.J., Rongen-Westerlaken, C. & Drop, S.L. (1999) Normalization of height in girls with Turner syndrome after long-term growth hormone treatment: results of a randomized dose-response trial. Journal of Clinical Endocrinology and Metabolism, 84, 4607-4612.
3. Ross, J.L., Cassorla, F.G., Skerda, M.C., Valk, I.M., Loriaux, D.L. & Cutler, G.B.J. (1983) A preliminary study of the effect of estrogen dose on growth in Turner's syndrome. New England Journal of Medicine, 309, 1104-1106.
4. Naeraa, R.W., Nielsen, J. & Kastrup, K.W. (1994) Growth hormone and 17 beta-oestradiol treatment of Turner girls - 2-year results. European Journal of Pediatrics, 153, 72-77.
5. Savendahl, L. & Davenport, M.L. (2000) Delayed diagnoses of Turner's syndrome: proposed guidelines for change. Journal of Pediatrics, 137, 455-459.
6. Caprio, S., Boulware, S.D., Press, M., Sherwin, R.S., Rubin, K., Carpenter, T.O., Plewe, G. & Tamborlane, W.V. (1992) Effect of growth hormone treatment on hyperinsulinemia associated with Turner syndrome. Journal of Pediatrics, 120, 238-243.
7. Sas, T.C., Muinck Keizer-Schrama, S.M., Stijnen, T, Aanstoot, H.J. & Drop, S.L. (2000) Carbohydrate metabolism during long-term growth hormone (GH) treatment and after discontinuation of GH treatment in girls with Turner syndrome participating in a randomized dose-response study. Dutch Advisory Group on Growth Hormone. Journal of Clinical Endocrinology and Metabolism, 85, 769-775.
8. Giustina, A. & Veldhuis, J.D. (1998) Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocrine Reviews, 19, 717-797.
9. Mauras, N., Rogol, A.D. & Veldhuis, J.D. (1989) Specific, time-dependent actions of low-dose ethinyl estradiol administration on the episodic release of growth hormone, follicle-stimulating hormone, and luteinizing hormone in prepubertal girls with Turner's syndrome. Journal of Clinical Endocrinology and Metabolism, 69, 1053-1058.
10. Jensen, M.B., Hermann, A.P., Hessov, I.B. & Mosekilde, L. (1997) Components of variance when assessing the reproducibility of body composition measurements using bio-impedance and the Hologic QDR-2000 DXA scanner. Clinical Nutrition, 16, 61-65.
11. Abrahamsen, B., Gram, J., Hansen, T.B. & Beck, N.H. (1995) Cross calibration of QDR-2000 and QDR-1000 dual-energy X-ray densitometers for bone mineral and soft-tissue measurements. Bone, 16, 385-390.
12. Matthews, D.R., Hosker, J.P., Rudenski, A.S., Naylor, B.A., Treacher, D.F. & Turner, R.C. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419.
13. Matsuda, M. & DeFronzo, R.A. (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care, 22, 1462-1470.
14. de Boer, J.A., Van der Veen, E.A. & Schoemaker, J. (1999) GH substitution does not alter the pulsatile pattern of LH in amenorrhoeic growth hormone deficient women. Clinical Endocrinology (Oxford), 51, 479-485.
15. Pasquino, A.M., Passeri, F., Pucarelli, I., Segni, M. & Municchi, G. (1997) Spontaneous pubertal development in Turner's syndrome. Italian Study Group for Turner's Syndrome. Journal of Clinical Endocrinology and Metabolism, 82, 1810-1813.
16. Naeraa, R.W., Gravholt, C.H., Kastrup, K.W., Svenstrup, B. & Christiansen, J.S. (2001) Morning versus evening administration of estradiol to girls with Turner syndrome receiving growth hormone: impact on growth hormone and metabolism. A randomized placebo-controlled crossover study. Acta Paediatrica, 90, 526-531.
17. Bidlingmaier, F., Wagner-Barnack, M., Butenandt, O. & Knorr, D. (1973) Plasma estrogens in childhood and puberty under physiologic and pathologic conditions. Pediatric Research, 7, 901-907.
18. Conte, F.A., Grumbach, M.M., Kaplan, S.L. & Reiter, E.O. (1980) Correlation of luteinizing hormone-releasing factor-induced luteinizing hormone and follicle-stimulating hormone release from infancy to 19 years with the changing pattern of gonadotropin secretion in agonadal patients: relation to the restraint of puberty. Journal of Clinical Endocrinology and Metabolism., 50, 163-168.
19. Wilson, C.A., Heinrichs, C., Larmore, K.A., Craen, M., Brown-Dawson, J., Shaywitz, S., Ross, J. & Klein, K.O. (2003) Estradiol levels in girls with Turner's syndrome compared to normal prepubertal girls as determined by an ultrasensitive assay. Journal of Pediatric Endocrinology and Metabolism, 16, 91-96.
20. Gravholt, C.H., Naeraa, R.W., Brixen, K., Kastrup, K.W., Mosekilde, L., Jørgensen, J.O. & Christiansen, J.S. (2002) Short term growth hormone treatment in girls with Turner syndrome decreases fat mass and insulin sensitivity. A randomized double-blind, placebo-controlled cross-over study. Pediatrics, 110, 889-896.
21. Caprio, S., Boulware, S., Diamond, M., Sherwin, R.S., Carpenter, T.O., Rubin, K., Amiel, S., Press, M. & Tamborlane, W.V. (1991) Insulin resistance: an early metabolic defect of Turner's syndrome. Journal of Clinical Endocrinology and Metabolism, 72, 832-836.
22. Stoppoloni, G., Prisco, F., Alfano, C., Iafusco, D., Marrazzo, G. & Paolisso, G. (1990) Characteristics of insulin resistance in Turner syndrome. Diabete et Metabolisme, 16, 267-271.
23. Gravholt, C.H. & Naeraa, R.W. (1997) Reference values for body proportions and body composition in adult women with Turner's syndrome. American Journal of Medical Genetics, 72, 403-408.
24. Gravholt, C.H., Lauridsen, A.L., Brixen, K., Mosekilde, L., Heickendorff, L. & Christiansen, J.S. (2002) Marked dysproportionality in bone size and mineral, and distinct abnormalities in bone markers and calcitropic hormones in adult Turner syndrome. A cross-sectional study. Journal of Clinical Endocrinology and Metabolism, 87, 2798-2808.
25. Hogler, W., Briody, J., Moore, B., Garnett, S., Lu, P.W. & Cowell, C.T. (2004) Importance of estrogen on bone health in Turner syndrome: a cross-sectional and longitudinal study using dual-energy X-ray absorptiometry. Journal of Clinical Endocrinology and Metabolism, 89, 193-199.
26. Van Pareren, Y.K., de Muinck Keizer-Schrama, S.M., Stijnen, T., Sas, T.C., Jansen, M., Otten, B.J., Hoorweg-Nijman, J.J., Vulsma, T., Stokvis-Brantsma, W.H., Rouwe, C.W., Reeser, H.M., Gerver, W.J., Gosen, J.J., Rongen-Westerlaken, C. & Drop, S.L. (2003) Final height in girls with Turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens. Journal of Clinical Endocrinology and Metabolism, 88, 1119-1125.
27. Massa, G., Heinrichs, C., Verlinde, S., Thomas, M., Bourguignon, J.P., Craen, M., Francois, I., Du, C.M., Maes, M. & De Schepper, J. (2003) Late or delayed induced or spontaneous puberty in girls with Turner syndrome treated with growth hormone does not affect final height. Journal of Clinical Endocrinology and Metabolism, 88, 4168-4174.
28. Chernausek, S.D., Attie, K.M., Gara, J.F., Rosenfeld, R.G. & Frane, J. (2000) Growth hormone therapy of Turner syndrome: the impact of age of estrogen replacement on final height. Genentech, Inc., Collaborative Study Group. Journal of Clinical Endocrinology and Metabolism, 85, 2439-2445.
29. Ross, J.L., Long, L.M., Loriaux, D.L. & Cutler, G.B.J. (1985) Growth hormone secretory dynamics in Turner syndrome. Journal of Pediatrics, 106, 202-206.
30. Zadik, Z., Landau, H., Chen, M., Altman, Y. & Lieberman, E. (1992) Assessment of growth hormone (GH) axis in Turner's syndrome using 24-hour integrated concentrations of GH, insulin-like growth factor-I, plasma GH-binding activity, GH binding to IM9 cells, and GH response to pharmacological stimulation. Journal of Clinical Endocrinology and Metabolism, 75, 412-416.
31. Wit, J.M., Massarano, A.A., Kamp, G.A., Hindmarsh, P.C., van Es, A., Brook, G.G., Preece, M.A. & Matthews, D.R. (1992) Growth hormone secretion in patients with Turner's syndrome as determined by time series analysis. Acta Endocrinologica, 127, 7-12.
32. Lanes, R., Brito, S., Suniaga, M., Moncada, G. & Borges, M. (1990) Growth hormone secretion in pubertal age patients with Turner's syndrome. Journal of Clinical Endocrinology and Metabolism, 71, 770-772.